These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 27910707)

  • 1. Standard hormone therapy is inadequate for bone density in premature ovarian insufficiency.
    Giraldo H; Benetti-Pinto C; Ferreira V; Garmes H; Yela D; Giraldo P
    Gynecol Endocrinol; 2017 Apr; 33(4):283-286. PubMed ID: 27910707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone mass in women with premature ovarian insufficiency: a comparative study between hormone therapy and combined oral contraceptives.
    Gazarra LBC; Bonacordi CL; Yela DA; Benetti-Pinto CL
    Menopause; 2020 Oct; 27(10):1110-1116. PubMed ID: 32576798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parathyroid hormone(1-84) treatment of postmenopausal women with low bone mass receiving hormone replacement therapy.
    Fogelman I; Fordham JN; Fraser WD; Spector TD; Christiansen C; Morris SA; Fox J
    Calcif Tissue Int; 2008 Aug; 83(2):85-92. PubMed ID: 18626566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone mineral density in young women with primary ovarian insufficiency: results of a three-year randomized controlled trial of physiological transdermal estradiol and testosterone replacement.
    Popat VB; Calis KA; Kalantaridou SN; Vanderhoof VH; Koziol D; Troendle JF; Reynolds JC; Nelson LM
    J Clin Endocrinol Metab; 2014 Sep; 99(9):3418-26. PubMed ID: 24905063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Hormone Replacement Therapy on Bone Mass After Allogeneic Hematopoietic Stem Cell Transplantation.
    Ha J; Park SS; Park S; Yoon JH; Baek KH; Kim HJ; Lee S; Kim MR; Kang MI; Lee JW
    J Clin Endocrinol Metab; 2020 Sep; 105(9):. PubMed ID: 32594134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study on risk factors of cardiovascular disease and the status of bone mineral density in women with hypoestrogenism].
    Zhao F; Guo XT; Cheng Y; Yang ZF; Liu HP
    Zhonghua Fu Chan Ke Za Zhi; 2013 Oct; 48(10):734-9. PubMed ID: 24406128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of hormone therapy on the bone density of women with premature ovarian insufficiency: A systematic review.
    Costa GPO; Ferreira-Filho ES; Simoes RDS; Soares-Junior JM; Baracat EC; Maciel GAR
    Maturitas; 2023 Jan; 167():105-112. PubMed ID: 36368093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal Trabecular Bone Score, Lower Bone Mineral Density and Lean Mass in Young Women With Premature Ovarian Insufficiency Are Prevented by Oestrogen Replacement.
    Samad N; Nguyen HH; Hashimura H; Pasco J; Kotowicz M; Strauss BJ; Ebeling PR; Milat F; Vincent AJ
    Front Endocrinol (Lausanne); 2022; 13():860853. PubMed ID: 35663323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Efficacy of Long-Term Estrogen Replacement Therapy in Turner Syndrome Women with Premature Ovarian Insufficiency.
    Son KA; Lee DY; Yoon BK; Choi D
    J Pediatr Adolesc Gynecol; 2019 Oct; 32(5):530-534. PubMed ID: 31145987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of continuous combined hormone replacement therapy and clodronate on bone mineral density in osteoporotic postmenopausal women: a 5-year follow-up.
    Tuppurainen M; Härmä K; Komulainen M; Kiviniemi V; Kröger H; Honkanen R; Alhava E; Jurvelin J; Saarikoski S
    Maturitas; 2010 Aug; 66(4):423-30. PubMed ID: 20547017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Women with primary ovarian insufficiency have lower bone mineral density.
    Amarante F; Vilodre LC; Maturana MA; Spritzer PM
    Braz J Med Biol Res; 2011 Jan; 44(1):78-83. PubMed ID: 21085897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing estrogen-based hormonal contraceptives and hormone therapy on bone mineral density in women with premature ovarian insufficiency: a systematic review.
    Fine A; Busza A; Allen LM; Kelly C; Wolfman W; Jacobson M; Lega IC
    Menopause; 2022 Feb; 29(3):351-359. PubMed ID: 35213521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exercise frequency and calcium intake predict 4-year bone changes in postmenopausal women.
    Cussler EC; Going SB; Houtkooper LB; Stanford VA; Blew RM; Flint-Wagner HG; Metcalfe LL; Choi JE; Lohman TG
    Osteoporos Int; 2005 Dec; 16(12):2129-41. PubMed ID: 16283062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poor Compliance to Hormone Therapy and Decreased Bone Mineral Density in Women with Premature Ovarian Insufficiency.
    Bachelot A; Nicolas C; Gricourt S; Dulon J; Leban M; Golmard JL; Touraine P
    PLoS One; 2016; 11(12):e0164638. PubMed ID: 27906970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Premature ovarian insufficiency in young girls: repercussions on uterine volume and bone mineral density.
    Bakhsh H; Dei M; Bucciantini S; Balzi D; Bruni V
    Gynecol Endocrinol; 2015 Jan; 31(1):65-9. PubMed ID: 25203144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Femora of women with premature ovarian insufficiency exhibit reduced strength and misalignment with the transmitted vertical forces from the upper body.
    Samad N; Nguyen HH; Aleksova J; Pasco JA; Kotowicz MA; Ebeling PR; Vincent AJ; Zebaze R; Milat F
    Eur J Endocrinol; 2024 Feb; 190(2):182-191. PubMed ID: 38064575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of low bone mass in postmenopausal Kuwaiti women residents in the largest province of Kuwait.
    Al-Shoumer KA; Nair V
    Arch Osteoporos; 2012; 7():147-53. PubMed ID: 23225292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of low-dose alendronate treatment on bone mineral density and bone turnover markers in Chinese postmenopausal women with osteopenia and osteoporosis.
    Li M; Zhang ZL; Liao EY; Chen DC; Liu J; Tao TZ; Wu W; Xia WB; Lu YJ; Sheng ZF; Lu CY; Meng GL; Xu L; Zhang WJ; Hu YY; Xu L
    Menopause; 2013 Jan; 20(1):72-8. PubMed ID: 22968256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone mineral density in women with cytotoxic-induced ovarian failure.
    Howell SJ; Berger G; Adams JE; Shalet SM
    Clin Endocrinol (Oxf); 1998 Sep; 49(3):397-402. PubMed ID: 9861333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen-based hormone therapy in women with primary ovarian insufficiency: a systematic review.
    Burgos N; Cintron D; Latortue-Albino P; Serrano V; Rodriguez Gutierrez R; Faubion S; Spencer-Bonilla G; Erwin PJ; Murad MH
    Endocrine; 2017 Dec; 58(3):413-425. PubMed ID: 29039146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.